SCSIO OpenIR  > 广东省海洋药物重点实验室
A new unsaturated glycoglycerolipid from a cultured marine dinofiagellate Amphidinium carterae
Wu, J; Long, LJ; Song, Y; Zhang, S; Li, QX; Huang, HS; Xiao, ZH; wwujun2003@yahoo.com
2005
发表期刊CHEMICAL & PHARMACEUTICAL BULLETIN
ISSN0009-2363
卷号53期号:3页码:330-332
摘要From the cultured marine dinoflagellate Amphidinium carterae, a new unsaturated glycoglycerolipid (2S)-1,2-O-6,9,12,15-dioctadecatetraenoyl-3-O-[alpha-D-galactopyranosyl-(1(nn)-> 6(m))-O-beta-D-galactopyranosyl]-glycerol (1), has been isolated together with two known saturated ones, (2S)-1,2-distearoyl-3-O-(6-sulpho-alpha-D-quinovopyranosyl)-glycerol (2) and (2S)-1-stearoyl-3-O-(6-sulpho-alpha-D-quinovopyranosyl)-glycerol (3). Their structures were elucidated on the basis of chemical and spectral data.
部门归属Chinese Acad Sci, S China Sea Inst Oceanol, Guangdong Key Lab Marine Mat Med, Guangzhou 510301, Peoples R China; Chinese Acad Sci, Trop Marine Biol Res Stn Hainan, Sanya 572000, Peoples R China
关键词Dinoflagellate Amphidinium Carterae Glycoglycerolipid
学科领域Chemistry, Medicinal ; Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
收录类别sci
资助项目广东省海洋药物重点实验室
WOS记录号WOS:000227710200016
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.scsio.ac.cn/handle/344004/2251
专题广东省海洋药物重点实验室
通讯作者wwujun2003@yahoo.com
推荐引用方式
GB/T 7714
Wu, J,Long, LJ,Song, Y,et al. A new unsaturated glycoglycerolipid from a cultured marine dinofiagellate Amphidinium carterae[J]. CHEMICAL & PHARMACEUTICAL BULLETIN,2005,53(3):330-332.
APA Wu, J.,Long, LJ.,Song, Y.,Zhang, S.,Li, QX.,...&wwujun2003@yahoo.com.(2005).A new unsaturated glycoglycerolipid from a cultured marine dinofiagellate Amphidinium carterae.CHEMICAL & PHARMACEUTICAL BULLETIN,53(3),330-332.
MLA Wu, J,et al."A new unsaturated glycoglycerolipid from a cultured marine dinofiagellate Amphidinium carterae".CHEMICAL & PHARMACEUTICAL BULLETIN 53.3(2005):330-332.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
A New Unsaturated Gl(77KB) 开放获取--请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。